Free Trial

ThermoGenesis (THMO) Competitors

ThermoGenesis logo

THMO vs. HTGMQ, OLITW, PRENW, QSIAW, SMAPW, TT, KEYS, VLTO, FTV, and TER

Should you be buying ThermoGenesis stock or one of its competitors? The main competitors of ThermoGenesis include HTG Molecular Diagnostics (HTGMQ), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), Trane Technologies (TT), Keysight Technologies (KEYS), Veralto (VLTO), Fortive (FTV), and Teradyne (TER). These companies are all part of the "measuring and control equipment" industry.

ThermoGenesis vs. Its Competitors

HTG Molecular Diagnostics (NASDAQ:HTGMQ) and ThermoGenesis (NASDAQ:THMO) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, institutional ownership, profitability, media sentiment, risk and dividends.

In the previous week, HTG Molecular Diagnostics' average media sentiment score of 0.00 equaled ThermoGenesis'average media sentiment score.

Company Overall Sentiment
HTG Molecular Diagnostics Neutral
ThermoGenesis Neutral

HTG Molecular Diagnostics has a beta of 2.67, suggesting that its stock price is 167% more volatile than the S&P 500. Comparatively, ThermoGenesis has a beta of 1.17, suggesting that its stock price is 17% more volatile than the S&P 500.

ThermoGenesis has higher revenue and earnings than HTG Molecular Diagnostics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HTG Molecular Diagnostics$6.37M0.00-$21.59MN/AN/A
ThermoGenesis$9.61M0.00-$17.98M-$5.14N/A

Company Net Margins Return on Equity Return on Assets
HTG Molecular DiagnosticsN/A N/A N/A
ThermoGenesis N/A N/A N/A

5.8% of ThermoGenesis shares are owned by institutional investors. 2.6% of HTG Molecular Diagnostics shares are owned by company insiders. Comparatively, 78.0% of ThermoGenesis shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

ThermoGenesis beats HTG Molecular Diagnostics on 4 of the 5 factors compared between the two stocks.

Get ThermoGenesis News Delivered to You Automatically

Sign up to receive the latest news and ratings for THMO and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

THMO vs. The Competition

MetricThermoGenesisLaboratory apparatus & furniture IndustryMedical SectorNASDAQ Exchange
Market Cap$1K$105.01M$5.70B$9.50B
Dividend YieldN/AN/A4.60%4.01%
P/E Ratio0.005.8328.1020.05
Price / SalesN/A0.48429.3789.38
Price / CashN/A45.3036.2258.56
Price / BookN/A2.708.665.87
Net Income-$17.98M$18.75M$3.25B$258.55M

ThermoGenesis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
THMO
ThermoGenesis
N/AN/AN/AN/A$1K$9.61M0.0040
HTGMQ
HTG Molecular Diagnostics
N/AN/AN/AN/A$0.00$6.37M0.0090
OLITW
OmniLit Acquisition
N/A$0.06
-16.4%
N/A-22.6%$0.00N/A0.003
PRENW
Prenetics Global
N/A$0.03
-1.4%
N/A+169.8%$0.00$41.52M0.001Positive News
Gap Down
QSIAW
Quantum-Si
N/A$0.60
0.0%
N/AN/A$0.00$3.44M0.00150Positive News
SMAPW
SportsMap Tech Acquisition
N/A$0.03
-8.5%
N/A+81.8%$0.00N/A0.00N/AGap Down
TT
Trane Technologies
4.5128 of 5 stars
$436.35
-0.6%
$437.80
+0.3%
+46.6%$97.31B$19.84B36.3045,000Positive News
Upcoming Earnings
KEYS
Keysight Technologies
4.0569 of 5 stars
$161.85
-0.9%
$183.00
+13.1%
+22.5%$27.86B$4.98B37.9915,500
VLTO
Veralto
2.7035 of 5 stars
$100.96
-1.2%
$110.09
+9.0%
+3.8%$25.02B$5.19B28.8517,000Positive News
Upcoming Earnings
FTV
Fortive
4.9631 of 5 stars
$51.13
-2.0%
$71.85
+40.5%
-26.4%$17.38B$6.23B22.4218,000Upcoming Earnings
Analyst Downgrade
TER
Teradyne
4.8728 of 5 stars
$93.03
-2.3%
$112.50
+20.9%
-27.5%$14.92B$2.82B26.286,500News Coverage
Upcoming Earnings

Related Companies and Tools


This page (NASDAQ:THMO) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners